147 related articles for article (PubMed ID: 35763911)
1. Prediction of the risk of cancer and the grade of dysplasia in leukoplakia lesions using deep learning.
Ferrer-Sánchez A; Bagan J; Vila-Francés J; Magdalena-Benedito R; Bagan-Debon L
Oral Oncol; 2022 Sep; 132():105967. PubMed ID: 35763911
[TBL] [Abstract][Full Text] [Related]
2. The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia.
Wils LJ; Poell JB; Peferoen LAN; Evren I; Brouns ER; de Visscher JGAM; van der Meij EH; Brakenhoff RH; Bloemena E
J Oral Pathol Med; 2023 Nov; 52(10):930-938. PubMed ID: 37749621
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
Gao Y; Guo ZL; Luo HY; Wang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
[TBL] [Abstract][Full Text] [Related]
5. Development of a Pathomics-Based Model for the Prediction of Malignant Transformation in Oral Leukoplakia.
Cai X; Li L; Yu F; Guo R; Zhou X; Zhang F; Zhang H; Zhang J; Li T
Lab Invest; 2023 Aug; 103(8):100173. PubMed ID: 37164265
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of relationship between risk factors of malignant transformation of oral leukoplakia and the LSCP system].
Sun Z; Gong Y; Huang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Sep; 36(5):364-6. PubMed ID: 11769652
[TBL] [Abstract][Full Text] [Related]
7. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
Xia RH; Song XM; Wang XJ; Li J; Mao L
PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
[TBL] [Abstract][Full Text] [Related]
8. Effect of clinical and histologic features on time to malignancy in 224 cases of oral leukoplakia treated by surgery.
Bagan J; Martorell M; Cebrián JL; Rubert A; Bagán L; Mezquida C; Hervás D
Clin Oral Investig; 2022 Aug; 26(8):5181-5188. PubMed ID: 35474554
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation of oral leukoplakia: a follow-up study.
Jayasooriya PR; Dayaratne K; Dissanayake UB; Warnakulasuriya S
Clin Oral Investig; 2020 Dec; 24(12):4563-4569. PubMed ID: 32436158
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
11. Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia.
Brouns ER; Evren I; Wils LJ; Poell JB; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Dis; 2023 Oct; 29(7):2667-2676. PubMed ID: 35765231
[TBL] [Abstract][Full Text] [Related]
12. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients.
Brouns E; Baart J; Karagozoglu Kh; Aartman I; Bloemena E; van der Waal I
Oral Dis; 2014 Apr; 20(3):e19-24. PubMed ID: 23521625
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis.
Dong Y; Chen Y; Tao Y; Hao Y; Jiang L; Dan H; Zeng X; Chen Q; Zhou Y
Lasers Med Sci; 2019 Feb; 34(1):209-221. PubMed ID: 30443884
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
[TBL] [Abstract][Full Text] [Related]
15. [Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression].
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Ned Tijdschr Tandheelkd; 2021 Feb; 128(2):103-111. PubMed ID: 33605260
[TBL] [Abstract][Full Text] [Related]
16. Improvement in the risk assessment of oral leukoplakia through morphology-related copy number analysis.
Li X; Liu L; Zhang J; Ma M; Sun L; Li X; Zhang H; Wang J; Huang Y; Li T
Sci China Life Sci; 2021 Sep; 64(9):1379-1391. PubMed ID: 34351567
[TBL] [Abstract][Full Text] [Related]
17. The treatment of oral leukoplakia with the CO2 laser: A retrospective study of 65 patients.
Mogedas-Vegara A; Hueto-Madrid JA; Chimenos-Küstner E; Bescós-Atín C
J Craniomaxillofac Surg; 2015 Jun; 43(5):677-81. PubMed ID: 25913630
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
19. Oral premalignant lesions: from a clinical perspective.
Amagasa T; Yamashiro M; Uzawa N
Int J Clin Oncol; 2011 Feb; 16(1):5-14. PubMed ID: 21225307
[TBL] [Abstract][Full Text] [Related]
20. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
Schepman KP; van der Meij EH; Smeele LE; van der Waal I
Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
